The Money Map folks have decided that it’s time to go “all in” on cannabis, and for them that means starting a new investment research business that they call the National Institute for Cannabis Investors, and selling memberships in that group by teasing their favorite “special reports” on some appealing marijuana stocks that they’ll give […]
Articles
Entry level research service that promises a new “Cannabis Investment Package” each month, recommending different stocks in the sector.
This article was originally published as part of the Friday File on August 10, 2018. It has not been updated or revised, though the stock teased is still at roughly the same price and no major news has hit since then. We’re breaking the Friday File up into two parts today — starting with this […]
Remember Ernie Tremblay’s pitch about a “tiny South Texas lab” that was about to cure every disease using its revolutionary CD19 Cancer Vaccine technology, and ignite a bidding war following its fantastical release of exciting information on June 23? Well, it’s back. Not the stock, that’s still languishing around where it was before Tremblay got […]
This Friday File article was originally released to the Irregulars on June 16, we have now opened it up for anyone to read in hopes of answering some questions that continue to roll in about the latest Biotech Insider Alert ads. The text below has not been updated or revised, though I and other readers […]
I know quite a few folks got to chatting about Bellicum (BLCM) following Ernie Tremblay’s overly heated pitch for the stock last week, covered in the Friday File a week ago… and, well, things so far are going as they often do: Overhype the ad, overpromise some dramatic results from a presentation that’s really much […]
Ernie Tremblay’s teaser pitches about imminent FDA decisions or other biotech catalysts always get a lot of attention — not necessarily because he’s always right (ARLZ did get approval for their drug, but the stock is actually down… EARS did not “double by August 31” because the trial he was teasing failed on efficacy), but […]
Another month, another big pitch about a biotech stock with a great “P-Value Indicator” from Ernie Tremblay, all in an ad for his Biotech Insider Alert. Should we pay attention? Well, we can hardly avoid noticing it — we’re being battered about the head and neck with the constant email fusillade from Tremblay’s publisher and […]
Ernie Tremblay is the name behind the Biotech Insider Alert newsletter ($1,950/year) at Money Map Press, and his claim is that he has a “P-Value” formula that helps him to identify biotech stocks that are about to release good data that can send their shares soaring. I’m not going to get into the actual “formula” […]
This ad first showed up in our inboxes under the “end surgery forever” headline in late January, and the following article first appeaered on January 26. We have not gone through and updated the article, though the basic pitch is just about the same in the new version of the ad today as it was […]
Golly, most people who might subscribe to investment newsletters are baby boomers. And most of that generation is just a few years past their midlife crisis… so you can be pretty sure that a “silent epidemic” will get them to read your ad, yes? Apparently so, if the questions rolling in to Gumshoe HQ over […]
Heads up: I made a mistake on this one when it first went up on the site. We strive for at least a 99% accuracy rate in identifying teaser targets, and this is apparently my mistake for 2014. Thanks to several readers for alerting me to the fact that I moved too quickly in posting […]
I know a great many of the Irregulars have been interested in FDA dates recently, partly thanks to the community of biotech enthusiasts who have coalesced around the musings of our own Dr. KSS, so I thought I’d spin out a quick answer to you for a teaser pitch that’s been sent out quite breathlessly […]
Newsletter/trading service that aims to track important trading catalyst dates for biotech stocks, including FDA approvals and submissions and clinical trial data releases. Formerly called BioScience Millionaire.
Comments
REITS gold Ernie Tremblay FDA options...
No, ANANDA, re $PGNX it was Ernie Tremblay of Biotech Insider Alert. It was discussed by Travis here; https://www.stockg...
I suspect the "urgency" of the impending deal hype By Ernie Tremblay had more to do with selling newsletters than predic...
What does Ernie Tremblay think of Bellicum Phrmaceuticals now? The share price is really dropping after poor 2nd quarter...
Does this promotion for Michael Robinson's newsletter mean that Ernie Tremblay is out of favour? I hope so....
New too buying stocks, within a few days I can see what teasing stocks is all about. People like Ernie Tremblay would b...
Just took a look at Bellicum, this is getting quite ridiculous a week after the ad got rolling. Money Map promos are so...
C D 19 Vaccine: Ernie Tremblay.... Interested to know what it is....
As a senior citizen who ended up in hospital with pneumonia 2 years ago the article by Ernie Tremblay about no new antib...
Ernie Tremblay teased "EARS" in Aug. this year. Stock dropped from $5.35 to less than $1 as of today. He & Dr. Moors...
I don't think I understand the question. If you're asking about those Ernie Tremblay teaser pitches, I wouldn't blame y...
I don't blame you, the teased picks based on expected trial or FDA news don't seem to be right about the direction any m...
Haven't seen Sid RIggs tout a $2 company recently, but all of the Money Map folks have been pretty aggressively re-circu...
Hi Travis What is the $2 surgical advancement that Ernie Tremblay is promoting?...
Just as an aside, am I the only one that feels Ernie Tremblay owes us an explanation and perhaps even an apology over t...
Hello Gummies, it's been a while since I've posted anything but this here has caught my attention. It is from Ernie Tre...
I don't know as much as Ernie Tremblay or Mike Ward about Biotech stocks either, but they are pulling out all stops on p...
POZN will probably DROP on Monday because of some screw up by the FDA, or so says Ernie Tremblay Of Bio Science Milliona...